Health
SARS-CoV-2 anti-nucleocapsid antibodies reduce risk of reinfection for at least eight months – News-Medical.Net
A new study concludes that at least with predominantly wild-type variants, the risk of reinfection with the virus among unvaccinated…
As the coronavirus disease 2019 (COVID-19) pandemic continues to take a heavy toll on the world population, scientists are seeking to identify the protective impact of prior infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
…
Continue Reading
-
General7 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
Business6 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General9 hours agoAlbanese beats drum on economy as trade clouds gather
-
Noosa News9 hours agoSurgeon partner of former premier to testify over his patient’s death